nVerses Capital LLC Invests $1.08 Million in The Clorox Company (NYSE:CLX)

nVerses Capital LLC acquired a new stake in shares of The Clorox Company (NYSE:CLX) in the 3rd quarter, according to the company in its most recent filing with the SEC. The institutional investor acquired 6,600 shares of the company’s stock, valued at approximately $1,075,000. Clorox comprises 0.5% of nVerses Capital LLC’s investment portfolio, making the stock its 17th largest holding.

A number of other institutional investors have also recently made changes to their positions in the business. SG Americas Securities LLC boosted its holdings in Clorox by 1,525.7% in the first quarter. SG Americas Securities LLC now owns 65,612 shares of the company’s stock worth $10,046,000 after acquiring an additional 61,576 shares in the last quarter. Mizuho Markets Americas LLC grew its position in Clorox by 93.7% during the 1st quarter. Mizuho Markets Americas LLC now owns 72,053 shares of the company’s stock worth $11,032,000 after purchasing an additional 34,864 shares during the last quarter. CANADA LIFE ASSURANCE Co increased its stake in Clorox by 15.2% during the 1st quarter. CANADA LIFE ASSURANCE Co now owns 141,622 shares of the company’s stock valued at $21,705,000 after purchasing an additional 18,687 shares in the last quarter. Advisors Asset Management Inc. increased its stake in Clorox by 257.5% during the 1st quarter. Advisors Asset Management Inc. now owns 11,228 shares of the company’s stock valued at $1,719,000 after purchasing an additional 8,087 shares in the last quarter. Finally, Game Plan Financial Advisors LLC purchased a new position in shares of Clorox in the first quarter worth $1,025,000. Institutional investors and hedge funds own 78.53% of the company’s stock.

Insiders Place Their Bets

In other news, EVP Angela C. Hilt sold 1,733 shares of the stock in a transaction dated Friday, September 6th. The shares were sold at an average price of $165.52, for a total value of $286,846.16. Following the completion of the sale, the executive vice president now directly owns 13,471 shares in the company, valued at $2,229,719.92. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 0.51% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

Several analysts have weighed in on CLX shares. Citigroup boosted their price target on Clorox from $165.00 to $170.00 and gave the company a “neutral” rating in a research note on Friday, September 6th. Deutsche Bank Aktiengesellschaft raised their price target on shares of Clorox from $144.00 to $151.00 and gave the stock a “hold” rating in a research report on Friday, August 2nd. Evercore ISI cut their price objective on shares of Clorox from $140.00 to $139.00 and set an “underperform” rating on the stock in a research note on Monday. JPMorgan Chase & Co. upped their price target on shares of Clorox from $148.00 to $174.00 and gave the company a “neutral” rating in a report on Friday, October 11th. Finally, Jefferies Financial Group upgraded Clorox from a “hold” rating to a “buy” rating and upped their target price for the stock from $174.00 to $187.00 in a research note on Tuesday, October 1st. Six investment analysts have rated the stock with a sell rating, nine have issued a hold rating and one has issued a buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and an average price target of $150.14.

Clorox Price Performance

Shares of NYSE CLX traded down $0.51 during trading on Thursday, hitting $162.92. The company had a trading volume of 74,648 shares, compared to its average volume of 1,230,436. The Clorox Company has a fifty-two week low of $114.68 and a fifty-two week high of $169.09. The company has a quick ratio of 0.63, a current ratio of 1.03 and a debt-to-equity ratio of 5.04. The stock has a fifty day simple moving average of $158.53 and a two-hundred day simple moving average of $144.98. The firm has a market capitalization of $20.23 billion, a price-to-earnings ratio of 84.68, a price-to-earnings-growth ratio of 3.19 and a beta of 0.41.

Clorox (NYSE:CLX) last posted its quarterly earnings data on Thursday, August 1st. The company reported $1.82 EPS for the quarter, topping the consensus estimate of $1.54 by $0.28. The company had revenue of $1.90 billion during the quarter, compared to analyst estimates of $1.97 billion. Clorox had a return on equity of 281.12% and a net margin of 3.95%. On average, research analysts expect that The Clorox Company will post 6.64 earnings per share for the current year.

Clorox Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, November 7th. Shareholders of record on Wednesday, October 23rd will be issued a $1.22 dividend. The ex-dividend date of this dividend is Wednesday, October 23rd. This represents a $4.88 dividend on an annualized basis and a yield of 3.00%. Clorox’s payout ratio is currently 252.85%.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.